Takeda at ESMO (Reynald Castaneda for Endpoints News)
October 24, 2023 06:30 AM EDT
R&D

Heard at #ES­MO23: No­var­tis and BeiGene fall­out; Now I know my AD­Cs; and a stand­ing ova­tion

Kyle LaHucik

Senior Reporter

Lei Lei Wu

News Reporter

Reynald Castañeda

Deputy Editor

MADRID — Over 31,000 peo­ple de­scend­ed up­on Madrid’s IFE­MA con­ven­tion cen­ter — host to the city’s bian­nu­al Fash­ion Week as well as the 2022 NA­TO Sum­mit …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

WuXi AppTec will sell cell and gene ther­a­py busi­ness to pri­vate eq­ui­ty firm

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

Deer­field wins fight to ac­quire Sin­gu­lar Ge­nomics, beat­ing out Tang Cap­i­tal’s Con­cen­tra

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

A service from the Financial Times